Abraxis Health Dedicates State of the Art Nanotechnology & Biologics Facility in Phoenix, Arizona
|
| Posted
:
Thu, 05 Nov 2009 01:15:38 GMT |
| Author
:
Abraxis BioScience, Inc.
|
| Category
:
Press Release |
| News Alerts by
Email ( click
here ) |
|
|
|
|
LOS ANGELES - (Business Wire) Abraxis Health, a fully-integrated personalized healthcare division of Abraxis BioScience, Inc. (NASDAQ:ABII), today announced the dedication of its new manufacturing facility in Phoenix, Arizona. The state of the art biopharma manufacturing plant represents a $70 million investment by LA-based Abraxis, and will create up to 200 high tech jobs. The new facility will manufacture ABRAXANE®, the first solvent-free chemotherapy treatment option for metastatic breast cancer, which was developed using Abraxis BioScience's proprietary nab® technology platform. The company now has multiple agreements in place for the development of novel, insoluble compounds using the nanobiologics technology employed at the Phoenix plant. The facility will be the world’s largest and most sophisticated protein nanobiologics manufacturing plant, with annual production capacity of over 10 million units, and the capability to expand to 20 million units, suitable for worldwide distribution. The site, formerly owned by Watson Pharmaceuticals, was purchased by Abraxis in July 2007. Abraxis has hired more than 100 former Watson employees, recruited additional staff from among the local skilled workforce, and will continue to recruit as the facility ramps up production. "The outlook for Abraxis is immensely encouraging," said founder and Chairman Dr. Patrick Soon-Shiong. “As we continue to grow, these new premises in Phoenix will become the flagship manufacturing facility for our cutting edge technology." State Attorney General Terry Goddard commented, “Arizona is proud to welcome Abraxis as a powerful new addition to our growing life sciences sector.” "This is great news for Phoenix," said Mayor Phil Gordon. "We are delighted that Abraxis has chosen our city for this state of the art nanotech manufacturing plant, bringing highly skilled jobs and a welcome boost for our economy.” State, city and business leaders attended today’s ceremony to dedicate the new facility, including Attorney General Goddard and Mayor Phil Gordon. About Abraxis BioScience, Inc. Abraxis Health, which will operate the Phoenix facility, is a division of Abraxis Bioscience Inc. Abraxis BioScience is a fully integrated global biotechnology company dedicated to the discovery, development and delivery of next-generation therapeutics and core technologies that offer patients safer and more effective treatments for cancer and other critical illnesses. The company's portfolio includes the world's first and only protein-bound nanoparticle chemotherapeutic compound (ABRAXANE®), which is based on the company's proprietary tumor targeting technology known as the nab® platform. The first FDA approved product to use this nab platform, ABRAXANE, was launched in 2005 for the treatment of metastatic breast cancer and is now approved in 38 countries. The company continues to expand the nab platform through a robust clinical program and deep product pipeline. Abraxis trades on the NASDAQ Global Market under the symbol ABII. For more information about the company and its products, please visit www.abraxisbio.com. Investors and Media Inquiries: Abraxis BioScience, Inc. Maili Bergman, 310-883-1300 investorrelations@abraxisbio.com
|

Copyright © 2008
Business Wire. All rights reserved.
|
|
|
|
|
Related
News
Ontario's Green Builder Abcott Construction are proud of our green LEED Partnership with Butler Manufacturing Ontario's Green Builder Abcott Construction are proud of our green LEED Partnership with Butler Manufacturing
Toronto Revitalization Infrastructure Project - LEEDing the way in Regent Park Demolition We are very proud of our Green Philosophy at
REC Demolition Restoration Environmental, we had an impressive acheivement of reaching 94.7% LEED success in three R's: Reduce, Recycle, Re-use a truly LEEDing the Way in Toronto a contractors success!
Fandango Sells a Record-Breaking 18% of 'New Moon' Opening Weekend Box Office
LOS ANGELES, Nov. 22 /PRNewswire/ -- Fandango, the nation's leading movie ticketing destination, announced today that it sold nearly 18% of all tickets for "The Twilight Saga: New Moon", which took in a projected domestic weekend box office of $140.7 million*.
(Pho...
Jennifer Jo Cobb Set to Drive the #84 MC2 Energy Drink Dodge at the Ford 300 NASCAR Nationwide Series Race at Homestead-Miami Speedway LAS VEGAS, NV and MOORESVILLE, NC -- 11/22/09 --
Beverage Plus Holdings
Corporation (PINKSHEETS: CLNP) and FCBBI AG (FRANKFURT: 3FC.de) and Mike
Harmon Racing announced today that Jennifer Jo Cobb will be behind the
wheel on the 1.5 mile Speedway i..
Klim USA Selects PLM, Sourcing from Centric Software
Focus on speeding sample development, on-time product design and delivery/I/P
PCampbell, Calif. (PRWEB) August 26, 2009 -- Klim USA, a rapidly growing maker of advanced technical riding gear for today's aggressive off-road dirt bike and snowmobile rider, has become the most recent appar...
Centric Software Hosts Customer Advisory Board Meeting
Focus on issues facing customers in fast-moving consumer goods, fashion industries/I/P
PCampbell, CA (PRWEB) September 30, 2009 -- Centric Software hosted a fashion and consumer goods Customer Advisory Board meeting last week in New York, New York.
The event included executives...
Daniel P. Quinn, Author of 'organized labor' (AuthorHouse), and Exits & Entrances, available for Interviews in 2009/10..
Daniel P Quinn's organized labor is a panoramic survey of labor history in poetic verse with historic photographs. From New York's Landmark Tavern in the 1890's to the 1913 strike at the Botto House Museum, Haledon, NJ. Mr. Quinn shapes a vision both old and new of his family history and tha...
|
|
|
|
|
|
|
|
|